Sarah Marktel

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications

Cytarabine as a salvage mobilization strategy after failure of cyclophosphamide-based stem cell collection for Daratumumab-treated multiple myeloma patients.

Cytarabine as a salvage mobilization strategy after failure of cyclophosphamide-based stem cell collection for Daratumumab-treated multiple myeloma patients.

Journal: Leukemia & lymphoma
Published: May 08, 2026

The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemia.

The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemia.

Journal: Frontiers in immunology
Published: February 26, 2026

CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report.

CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report.

Journal: Current research in translational medicine
Published: May 26, 2025

Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy.

Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy.

Journal: American journal of hematology
Published: March 14, 2025

Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients.

Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients.

Journal: Bone marrow transplantation
Published: March 03, 2025

Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab.

Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab.

Journal: Haematologica
Published: February 05, 2025

Real-world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study.

Real-world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study.

Journal: British journal of haematology
Published: November 16, 2024

Impact of Respiratory Syncytial Virus (RSV) on adult haematology oncology patients.

Impact of Respiratory Syncytial Virus (RSV) on adult haematology oncology patients.

Journal: The Journal of infection
Published: October 17, 2024

Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia.

Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia.

Journal: Nature communications
Published: June 02, 2024

Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities.

Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities.

Journal: The Journal of allergy and clinical immunology
Published: May 06, 2024

Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience.

Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience.

Journal: Frontiers in oncology
Published: February 26, 2024

Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients.

Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients.

Journal: Therapeutic advances in infectious disease
Published: January 19, 2024
Showing 1-12 of 78

Last Updated: 09/26/2026